Levothyroxine (Compound)

Synonyms:L-thyroxine, levothyroxine, 51-48-9, thyroxine, thyroxin, Levothyroxin, Tetraiodothyronine, Thyrax, 3,3',5,5'-Tetraiodo-L-thyronine, synthroid, Thyratabs, Thyreoideum, Thyroxinal, Thyroxine iodine, 3,5,3',5'-Tetraiodo-L-thyronine, L-T4, (-)-Thyroxine, L-Thyroxin, Thyroxine (l), Levothyroxine sodium, levothroid, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine, Levoxyl, t4, DL-Thyroxin, Thyroxine (VAN), eltroxin, 3,5,3',5'-Tetraiodothyronine, Laevothyroxinum, L-3,5,3',5'-Tetraiodothyronine, Levothyroxinum (acid), Laevothyroxinum (acid), Thryroxine, l-, Thyroxine, L-, Tetramet, Forthyron (TN), O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine, NSC 36397, Levothyroxinum, 3,3',5,5''-Tetraiodo-L-thyronine, CCRIS 6739, Henning, HSDB 3108, L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, 3,5,3'5'-Tetraiodo-L-thyronine, Prestwick_548, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine, CHEBI:18332, Synthetic levothyroxine, O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine, L-Thyroxine, free acid, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid, 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine, beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine, 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine, CHEMBL1624, Q51BO43MG4, DTXSID8023214, THX, MFCD00002595, NSC-36397, NCGC00164336-01, (S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid, DTXCID603214, Levothyroxine;T4, Eutirox, Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, Sodium levothyroxine pentahydrate, LT4, SMR000059176, T44, Levothyroxine (BAN), EINECS 200-101-1, Levothyroxine [INN:BAN], Synthroid (*Sodium salt*), BRN 2228515, UNII-Q51BO43MG4, SR-01000759430, 2ceo, CAS-51-48-9, Spectrum_001076, 1hk1, 1hk2, 1hk3, 1hk4, 1hk5, 1y0x, CPD000059176, SpecPlus_000871, THYROXINE [MI], Prestwick0_000403, Prestwick1_000403, Prestwick2_000403, Prestwick3_000403, Spectrum2_000573, Spectrum3_000611, Spectrum4_000128, Spectrum5_001500, bmse000923, Epitope ID:123889, T-3850, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid, LEVOTHYROXINE [HSDB], BIDD:PXR0161, Levothroid (*Sodium salt*), SCHEMBL23098, BSPBio_000326, BSPBio_002142, KBioGR_000516, KBioSS_001556, LEVOTHYROXINE [VANDF], MLS000028647, MLS002548901, DivK1c_006967, SPECTRUM1500774, SPBio_000386, SPBio_002265, LEVOTHYROXINE [USP-RS], LEVOTHYROXINE [WHO-DD], BPBio1_000360, GTPL2635, KBio1_001911, KBio2_001556, KBio2_004124, KBio2_006692, KBio3_001642, HMS1569A08, HMS1921I06, HMS2090P18, HMS2092K12, HMS2096A08, HMS2233J18, HMS3259M11, HMS3713A08, L-Thyroxine, >=98% (HPLC), Pharmakon1600-01500774, Tox21_112101, Tox21_302156, BDBM50301375, CCG-38738, NSC757434, s2599, AKOS015905129, Tox21_112101_1, AC-7504, AM83594, CS-1819, DB00451, NC00485, NSC-757434, SDCCGMLS-0066571.P001, 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid, 3,3'',5,5''-tetraiodo-L-thyronine, 3,5,3'',5''-tetraiodo-L-thyronine, SK&F 1-6528, NCGC00094852-03, NCGC00164336-02, NCGC00164336-03, NCGC00164336-04, NCGC00164336-05, NCGC00164336-06, NCGC00255368-01, AC-10465, AS-81045, HY-18341, SBI-0051608.P002, DB-006261, SW196731-3, C01829, D08125, D78141, EN300-708765, AB00052176-08, AB00052176_09, AB00052176_10, Q773449, SR-05000001567, LIOTHYRONINE SODIUM IMPURITY A [EP IMPURITY], SR-01000759430-2, SR-05000001567-1, BRD-K30685142-001-05-5, BRD-K30685142-001-08-9, Thyroxine (T4), IRMM(R) certified Reference Material, L-Thyroxine, powder, BioReagent, suitable for cell culture, L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, Levothyroxine, United States Pharmacopeia (USP) Reference Standard, (-)-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3, 5-diiodophenyl]propanoic acid, (S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoicacid, Levothyroxine, Pharmaceutical Secondary Standard; Certified Reference Material

Id:5819

Description:nan